cyclohexanol has been researched along with Prostatic Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, PT; Frizzell, B; Griffin, L; Lesser, GJ; Moose, D; Naughton, M; Radford, JE; Shaw, EG; Tomlinson, WV; Vitolins, MZ; Vuky, J | 1 |
| Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L | 1 |
| Stearns, V | 1 |
| Baum, NH; Torti, DC | 1 |
| Antolak, SJ; Burch, PA; Loprinzi, CL; Novotny, P; Perez, EA; Pisansky, TM; Quella, SK; Sloan, J | 1 |
2 review(s) available for cyclohexanol and Prostatic Neoplasms
| Article | Year |
|---|---|
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Managing hot flashes in men being treated for prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Complementary Therapies; Cyclohexanols; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms; Testosterone; Venlafaxine Hydrochloride | 2007 |
3 trial(s) available for cyclohexanol and Prostatic Neoplasms
| Article | Year |
|---|---|
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyclohexanols; Double-Blind Method; Hot Flashes; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Soybean Proteins; Venlafaxine Hydrochloride | 2013 |
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Severity of Illness Index; Venlafaxine Hydrochloride | 1999 |